Annex Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-546
Closed -$284K 315
2024
Q3
$284K Hold
546
0.01% 234
2024
Q2
$296K Buy
546
+5
+0.9% +$2.64K 0.01% 227
2024
Q1
$281K Sell
541
-3
-0.6% -$1.49K 0.01% 235
2023
Q4
$257K Buy
544
+3
+0.6% +$1.39K 0.01% 231
2023
Q3
$236K Hold
541
0.01% 226
2023
Q2
$240K Hold
541
0.01% 221
2023
Q1
$249K Sell
541
-7
-1% -$3.33K 0.01% 203
2022
Q4
$281K Buy
548
+7
+1% +$3.55K 0.02% 193
2022
Q3
$246K Hold
541
0.02% 196
2022
Q2
$261K Sell
541
-21
-4% -$10.4K 0.02% 205
2022
Q1
$276K Hold
562
0.02% 201
2021
Q4
$261K Hold
562
0.02% 204
2021
Q3
$209K Sell
562
-20
-3% -$7.6K 0.02% 194
2021
Q2
$222K Sell
582
-30
-5% -$11.5K 0.02% 204
2021
Q1
$220K Buy
+612
New +$197K 0.02% 187
2020
Q4
Sell
-1,057
Closed -$284K 194
2020
Q3
$284K Sell
1,057
-1
-0.1% -$269 0.04% 109
2020
Q2
$278K Sell
1,058
-47
-4% -$12.5K 0.04% 104
2020
Q1
$251K Sell
1,105
-412
-27% -$112K 0.04% 107
2019
Q4
$458K Buy
1,517
+37
+3% +$10.2K 0.06% 89
2019
Q3
$355K Sell
1,480
-6,991
-83% -$1.92M 0.05% 92
2019
Q2
$2.39M Buy
8,471
+2,441
+40% +$667K 0.34% 33
2019
Q1
$1.73M Sell
6,030
-213
-3% -$61.6K 0.26% 45
2018
Q4
$1.64M Buy
6,243
+300
+5% +$82.5K 0.26% 52
2018
Q3
$1.63M Buy
5,943
+496
+9% +$129K 0.25% 53
2018
Q2
$1.3M Buy
5,447
+397
+8% +$91.9K 0.22% 61
2018
Q1
$1.11M Buy
5,050
+480
+11% +$113K 0.2% 62
2017
Q4
$1.03M Buy
4,570
+295
+7% +$62.8K 0.19% 58
2017
Q3
$812K Buy
4,275
+321
+8% +$61.1K 0.17% 65
2017
Q2
$744K Buy
3,954
+511
+15% +$91.8K 0.17% 63
2017
Q1
$569K Buy
+3,443
New +$548K 0.14% 70

Other funds holding ELV

Annex Advisory Services's ELV Position: Q4 2024 in Review

Annex Advisory Services sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 546 shares — an estimated $284K sold.

Annex Advisory Services first reported a position in ELV in Q1 2017 and held it in 30 quarters. The position peaked at $2.39M in Q2 2019. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Annex Advisory Services reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Annex Advisory Services sold 546 Elevance Health shares in Q4 2024, an estimated $284K.
  • Annex Advisory Services first reported a position in Elevance Health in Q1 2017 and held it in 30 quarters.
  • Annex Advisory Services's Elevance Health position peaked at $2.39M in Q2 2019.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Annex Advisory Services's 13F filing for Q4 2024, filed 16 Jan 2025.